IP Library Granted Patent US 12,420,239
Granted Patent B2
US 12,420,239 · App. 17/766,699 · Granted Sep 23, 2025

Surface modified polyethersulfone membranes and method of making thereof

Inventors: Sven Frost (Essen, DE); Pierre-Alexandre Bourgeois (Essen, DE); Frans A. Audenaert (Kaprijke, BE); Tim Wolf (Düsseldorf, DE); Tom Opstal (Kalken, BE)
Assignee: Solventum Intellectual Properties Company
B01D67/00931B01D67/0088B01D67/009B01D69/06B01D69/08B01D71/68B01D2323/34B01D2325/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,420,239
App. No.
17/766,699
Granted
Sep 23, 2025
Kind
B2
Abstract

The present disclosure is related to a polymeric membrane, comprising a modified surface obtained from coating with hydrophilic monomers and curing the hydrophilic monomers with electron beam, wherein the hydrophilic monomers comprise at least one amino moiety, at least one polyoxyalkylene unit, and at least one (meth)acrylate moiety.

Claims (17)

1. A polymeric membrane, comprising a modified surface obtained from coating with hydrophilic monomers and curing the hydrophilic monomers with electron beam,

wherein the hydrophilic monomers comprise:

(i) at least one amino moiety;

(ii) at least one polyoxyalkylene unit; and

(iii) at least one (meth)acrylate moiety;

wherein said polymeric membrane is a porous polymer membrane; and

wherein the hydrophilic monomers are according to any one of formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), (XI), (XII), (XIII), or (XIV):

wherein R is a linear or branched alkyl or alkoxy,

wherein m and n may be different or the same,

wherein m and n may each be in a range of from 1 to 100,

wherein x, y, z may be different or the same,

wherein x, y, z may be each in a range of from 1 to 100.

2. The polymeric membrane according to claim 1 , wherein the polymeric membrane is selected from polymeric sulfone membranes, polyethylene membranes, polypropylene membranes, polyvinylidene difluoride membranes and polyacrylonitrile membranes.

3. The polymeric membrane according to claim 1 , wherein the at least one polyoxyalkylene unit of the hydrophilic monomers is selected from polyethers.

4. The polymeric membrane according to claim 1 , wherein the at least one amino moiety of the hydrophilic monomers is at least one secondary amino moiety and/or at least one tertiary amino moiety.

5. The polymeric membrane according to claim 1 , wherein the hydrophilic monomers comprise acrylate moieties in an amount of from 1 to 10, preferably from 1 to 8, more preferably from 1 to 6.

6. The polymeric membrane according to claim 1 , wherein, when an amount of immunoglobulin G (IgG) is adsorbed to said modified surface of said polymeric membrane, the amount of the IgG adsorbed to said modified surface of the polymeric membrane is lower than 16 μg/cm 2 , preferably lower than 15 μg/cm 2 , and more preferably lower than 14 μg/cm 2 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2022
From: FROST, SVEN; BOURGEOIS, PIERRE-ALEXANDRE; AUDENAERT, FRANS A.; WOLF, TIM; OPSTAL, TOM
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 059508/0378 →
Priority Claims (1)
EP 19208130 · Nov 8, 2019 · regional
Continuity (1)
Related Publication 20240100486A1 · Mar 28, 2024
References Cited (24)
US 4944879A · Steuck · 1990 [cited by applicant]
US 5468390A · Crivello et al. · 1995 [cited by applicant]
US 6852769B2 · Belfort et al. · 2005 [cited by applicant]
US 7073671B2 · Charkoudian · 2006 [cited by applicant]
US 9045602B2 · Thom et al. · 2015 [cited by applicant]
US 20090188857A1 · Moore et al. · 2009 [cited by applicant]
US 20100210160A1 · Hester et al. · 2010 [cited by applicant]
US 20110120941A1 · Allen · 2011 [cited by examiner]
US 20120135149A1 · Buskens · 2012 [cited by examiner]
US 20160236154A1 · Dubois et al. · 2016 [cited by applicant]
CN 106621851A · 2017 [cited by applicant]
CN 106634276A · 2017 [cited by applicant]
CN 107303470B · 2020 [cited by applicant]
KR 20140096628A · 2014 [cited by applicant]
KR 20140100317A · 2014 [cited by applicant]
WO 2010108985A1 · 2010 [cited by applicant]
WO 2011069050A1 · 2011 [cited by applicant]
WO 2013114297A1 · 2013 [cited by applicant]
WO 2014112689A1 · 2014 [cited by applicant]
WO 2020003216A1 · 2020 [cited by applicant]
WO 2021090216A1 · 2021 [cited by applicant]
WO 2021090217A1 · 2021 [cited by applicant]
1507 Extended EP Search Report for E19208130.5, PCT/IB2020/060393, Apr. 9, 2020, 3 pages. [cited by applicant]
International Search report for PCT International Application No. PCT/IB2020/060393 mailed on Jan. 22, 2021, 5 pages. [cited by applicant]